Global Diabetes Diagnostics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Diabetes Diagnostics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Health care professional can diagnose diabetes, prediabetes, and gestational diabetes through blood tests. Blood tests show whether blood sugar is too high.

Anyone who has symptoms of diabetes should be tested for the disease. Some people will not have any symptoms but may have risk factors for diabetes and need to be tested. Testing allows health care professionals to find diabetes sooner and work with their patients to manage diabetes and prevent complications. Testing also allows health care professionals to find prediabetes.

Market Overview:

The latest research study on the global Diabetes Diagnostics market finds that the global Diabetes Diagnostics market reached a value of USD 27997.33 million in 2022. It’s expected that the market will achieve USD 44481.8 million by 2028, exhibiting a CAGR of 8.02% during the forecast period.

Affect the normal operation of the industry

The raging COVID-19 has left the global economic environment in depression. The impact of COVID-19 on the Diabetes Diagnostics industry will involve all major links and all entities in the industry chain.
Equipment production, company operation and logistics delivery speed of Diabetes Diagnostics are affected to varying degrees. In addition, affected by the epidemic blockade, the offline sales volume decreased. The severity of the epidemic impact on Diabetes Diagnostics market depends on the prevention and control effect of each region.

Covid-19 will influence the education and training of diabetes management in the short term

The response of various countries to COVID-19 has led to the redeployment of medical resources and the reconfiguration of medical services. Redeployment and new working methods will inevitably affect the education and training of health care providers in diabetes management.
The long-term medical effects of social blockade may not appear for some time. In the short term, the interruption of daily activities, including diet and exercise, may have a significant impact on blood sugar control, as well as anxiety and sleep disorders. Most structured diabetes education is provided through suspended group education, which may not be restarted for a period of time.

Region Overview:

In global comparison, a significant portion of the revenue was generated in North America (35.69% in 2021).

Company Overview:

Abbott Diabetes Care Inc. is one of the major players operating in the Diabetes Diagnostics market, holding a share of 15.58% in 2021.

Abbott Diabetes Care Inc.

Abbott Diabetes Care Sales Corporation designs, develops, manufactures, and markets glucose monitoring systems. The Company offers blood glucose monitoring systems and test strips, blood glucose and Ketone monitoring systems, Ketone test strips, and precision insulin syringes.

DexCom Inc.

DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps.

Segmentation Overview:

Among different product types, Analog Glucose Monitors segment is anticipated to contribute the largest market share in 2027.

Biochips

The biochip is used to simultaneously analyze a panel of related tests in a single sample, producing a patient profile. The patient profile can be used in disease screening, diagnosis, monitoring disease progression or monitoring treatment.
Biochip can measure glucose concentrations in human saliva. The technique could eliminate the need for diabetics to draw blood to check their glucose levels.

Test Strips

Diabetes test strips are a key component of blood glucose testing. When blood is placed onto the test strip, it reacts with a chemical called glucose oxidase producing gluconic acid from the glucose in the blood. At the other end of the test strip, the meter transfers a current to the test strip. The test strip has electric terminals which allow the meter to measure the current between the terminals. The current between the terminals changes depending on the level of gluconic acid that has been produced. The blood glucose meter then uses an algorithm to work out the blood glucose level based upon the difference in current.

Lancets

Lancets are the small, sharp objects that are used to prick the skin. This piercing of the skin allows patient to draw a small drop of blood to the surface in order to test blood glucose levels using a blood glucose monitor and blood glucose test strips.

Analog Glucose Monitors

Analog glucose monitors are traditional blood glucose meters that uses a blood sample drawn from pricking a patient`s finger or another place on the body.

Continuous Glucose Monitors

Continuous glucose monitoring automatically tracks blood glucose levels, also called blood sugar, throughout the day and night. User can see glucose level anytime at a glance. User can also review how glucose changes over a few hours or days to see trends. It’s not an understatement to say that CGMs have revolutionized diabetes care. Unlike a traditional fingerstick blood glucose meter (BGM), which provides just a single glucose reading, CGM systems provide continuous, dynamic glucose information every five minutes. That equates to roughly 288 readings in a day.

Application Overview:

The market's largest segment by application is the segment Homecare Settings, with a market share of 47.86% in 2021.

Hospitals

Hospital is a professional institution or academic health institution that provides medical services, and it is a service place for receiving and treating patients. Hospitals accept all types of medical and surgical cases, including patients with various acute diseases.

Clinics

Clinic is a kind of sanitary place which mainly pays attention to the nursing of outpatients. Clinics can be run by the private sector or run and funded by the public. Clinics are usually small, but they are more efficient. They usually provide some simple care and treatment for patients, while large hospitals provide more professional treatment.

Diagnostics Centers

The diagnostic center usually provides patients with radiographic diagnosis, aiming at neurology, psychiatry or other clinical departments.

Homecare Settings

Home health care is a wide range of health care services that can be given in your home for an illness or injury. Home health care is usually less expensive, more convenient, and just as effective as care you get in a hospital or skilled nursing facility (SNF).

Key Companies in the global Diabetes Diagnostics market covered in Chapter 3:

DexCom Inc.
Bio-Rad Laboratories Inc.
ARKRAY Inc.
Sinocare, Inc.
BIONIME Corporation
Medtronic PLC
B. Braun Melsungen AG
Siemens Healthineers
Beckman Coulter Inc.
EKF Diagnostics Holdings Plc
Nova Biomedical Corporation
AgaMatrix Inc.
Ascensia Diabetes Care Holdings AG
A.Menarini Diagnostics Ltd.
LifeScan, Inc.
Acon Laboratories Inc.
Apex Biotechnology Corporation
Abbott Diabetes Care Inc.
HemoCue
Roche Diabetes Care, Inc.

In Chapter 4 and Chapter 14.2, on the basis of types, the Diabetes Diagnostics market from 2018 to 2029 is primarily split into:

Biochips
Test Strips
Lancets
Analog Glucose Monitors
Continuous Glucose Monitors
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Diabetes Diagnostics market from 2018 to 2029 covers:

Hospitals
Clinics
Diagnostics Centers
Homecare Settings
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)